Title:
Chronic obstructive pulmonary disease improvement agent
Document Type and Number:
Japanese Patent JP6013450
Kind Code:
B2
Abstract:
This invention provides a safe and effective agent for ameliorating chronic obstructive pulmonary disease (COPD) that has both a bronchodilator effect and an anti-inflammatory effect. The agent for ameliorating chronic obstructive pulmonary disease contains mepenzolate bromide as an active ingredient. More preferably the mode of administration of the agent for ameliorating chronic obstructive pulmonary disease is airway administration or inhalation administration, and furthermore the mode of administration thereof is oral administration or rectal administration. This invention is a safe and effective agent for ameliorating chronic obstructive pulmonary disease (COPD) that has both a bronchodilator effect and an anti-inflammatory effect of mepenzolate bromide.
More Like This:
Inventors:
Toru Mizushima
Liu Bensei
Liu Bensei
Application Number:
JP2014504789A
Publication Date:
October 25, 2016
Filing Date:
February 28, 2013
Export Citation:
Assignee:
LTT Biopharma Co., Ltd.
International Classes:
A61K31/452; A61P11/00
Domestic Patent References:
| JP2008506674A |
Foreign References:
| WO2009142589A1 |
Other References:
Digestion & Absorption,2005年,Vol.28, No.1,pp.105-108
THE LUNG perspectives,2008年,Vol.16, No.1 ,pp.53-56
THE LUNG perspectives,2008年,Vol.16, No.1 ,pp.53-56
Attorney, Agent or Firm:
Kusama attack